SynthesisEndocrine2026

BRAF/MEK inhibitors for redifferentiation in patients with radioiodine refractory thyroid cancer: A systematic review and Meta-Analysis.

Kexin Shi et al.PubMed ↗Publisher ↗

No numbers read from the abstract.